Filing Details
- Accession Number:
- 0001628945-22-000186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-07 21:11:17
- Reporting Period:
- 2022-12-05
- Accepted Time:
- 2022-12-07 21:11:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1628945 | Cue Health Inc. | HLTH | Laboratory Analytical Instruments (3826) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1868945 | Clint Sever | C/O Cue Health Inc. 4980 Carroll Canyon Rd. Suite 100 San Diego CA 92121 | Chief Product Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-12-05 | 10,633 | $3.05 | 3,939,647 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2022-12-06 | 26,664 | $0.20 | 3,966,311 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-06 | 26,664 | $3.14 | 3,939,647 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-12-07 | 24,147 | $0.20 | 3,963,794 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-07 | 24,147 | $2.98 | 3,939,647 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2022-12-06 | 26,664 | $0.00 | 26,664 | $0.20 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2022-12-07 | 24,147 | $0.00 | 24,147 | $0.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 53,416 | 2022-12-31 | No | 4 | M | Direct | |
| 29,269 | 2022-12-31 | No | 4 | M | Direct |
Footnotes
- The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units.
- Includes 877,772 unvested RSUs.
- The transactions reported on this Form 4 were automatically effected pursuant to a rule 10b5-1 trading plan adopted on June 6, 2022 and established by the reporting person for the purpose of an orderly sale of shares related to the exercises of options scheduled to expire on December 31, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.03 to $3.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.91 to $3.04, inclusive.
- Shares subject to the option are fully vested and immediately exercisable.
Billionaire Hedge Funds
